|
|
|
|
| Advertisement |
 |
|
|
| Branding |
|
|
When One is Not Enough |
In addition to the “new brand for new indication” approach, drug manufacturers have also re-launched a drug as a distinct second brand within the same indication. Ram Subramanian and Rehan Baqri lay out five objectives that make it worthwhile to pursue a second brand strategy
... /Read more/ |
|
| Advertisement |
CHI’s 15th Annual Bio-IT World Conference & Expo
April 5-7, 2016 – Boston, MA
Building a global network for precision medicine by uniting the Bio-IT community. Event includes 13 parallel conference tracks, 16 pre-conference workshops, 200+ presentations, 3,000+ global attendees, and an expansive exhibit/poster hall.
For full details and to register, visit  http://www.bio-itworldexpo.com. |
|
| Forecast |
|
|
Pharm 2016: Hot Topics, Burning Questions
|
Pharm Exec Editorial Advisory Board member Cliff Kalb poses some of the pertinent questions he expects the pharma industry will be asking this year, on topics from healthcare convergence to geographic opportunities
... /Read more/ |
|
|
| US Election |
|
|
Presidential Candidates & Rx Policy
|
Tom Norton
As the nation heads towards its first presidential primaries of the 2016 election, it’s important for American pharm execs to consider where the leading candidates stand on U.S. Rx policy. Tom Norton takes a closer look
... /Read more/ |
|
|
|
|
| Industry update |
| //Achillion Pharmaceuticals, Inc. (New Haven, CT) recruited Martha Manning Executive Vice President, General Counsel and Secretary, and Amy Jennings, Ph.D., as Senior Vice President of Regulatory Affairs.//Paragon Bioservices, Inc. (Baltimore, MD) elected the company's founder, Dr. Marco Chacon, as Chairman of the Company's Board of Directors.//Deltanoid Pharmaceuticals, Inc. appointed former Genzyme/Sanofi renal head, Douglas Jermasek, as its new Chief Executive Officer. Co-founder Hector F DeLuca, Ph.D., MD, DSC will continue as Chairman of the Board of Directors and assume the responsibilities of President and Chief Operating Officer. Co-founder Margaret Clagett-Dame, Ph.D., will continue in her role as Executive Vice President.// |
|
|
| Advertisement |
 |
|
|
| |
|
|
